Free Trial

Inozyme Pharma (INZY) Earnings Date, Estimates & Call Transcripts

$4.70
-0.03 (-0.63%)
(As of 05/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(Mar. 12)
-$0.35 Missed By -$0.04
Consensus EPS
(Mar. 12)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data

INZY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INZY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Inozyme Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.35)($0.33)($0.34)
Q2 20242($0.40)($0.39)($0.40)
Q3 20242($0.42)($0.38)($0.40)
Q4 20242($0.46)($0.39)($0.43)
FY 20248($1.63)($1.49)($1.56)
Q1 20251($0.46)($0.46)($0.46)
Q2 20251($0.38)($0.38)($0.38)
Q3 20251($0.37)($0.37)($0.37)
Q4 20251($0.37)($0.37)($0.37)
FY 20254($1.58)($1.58)($1.58)

INZY Earnings Date and Information

Inozyme Pharma last released its quarterly earnings results on March 12th, 2024. The reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.04. Inozyme Pharma has generated ($1.37) earnings per share over the last year (($1.37) diluted earnings per share). Earnings for Inozyme Pharma are expected to decrease in the coming year, from ($1.59) to ($1.61) per share. Inozyme Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Inozyme Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
3/12/2024Q4 2023($0.31)($0.35)($0.04)($0.35)--
11/7/2023Q3 2023($0.32)($0.29)+$0.03($0.29)--
8/8/2023Q2 2023($0.43)($0.35)+$0.08($0.35)--
5/9/2023Q1 2023($0.44)($0.40)+$0.04($0.40)--
3/22/2023Q4 2022($0.46)($0.42)+$0.04($0.42)--
11/10/2022Q3 2022($0.43)($0.38)+$0.05($0.38)--
8/15/2022Q2 2022($0.48)($0.38)+$0.10($0.38)--
5/10/2022Q1 2022($0.81)($0.71)+$0.10($0.71)--    
3/15/2022Q4 2021($0.73)($0.79)($0.06)($0.79)--
11/9/2021Q3 2021($0.61)($0.60)+$0.01($0.60)--
8/11/2021Q2 2021($0.57)($0.53)+$0.04($0.53)--
5/12/2021Q1($0.5420)($0.47)+$0.0720($0.47)--
3/24/2021Q4 2020($0.55)($1.01)($0.46)---
11/12/2020Q3 2020($0.51)($1.55)($1.04)($1.55)--
9/3/2020Q2($1.4130)($7.57)($6.1570)($7.57)--

Inozyme Pharma Earnings - Frequently Asked Questions

When is Inozyme Pharma's earnings date?

Inozyme Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on INZY's earnings history.

Did Inozyme Pharma beat their earnings estimates last quarter?

In the previous quarter, Inozyme Pharma (NASDAQ:INZY) missed the analysts' consensus estimate of ($0.31) by $0.04 with a reported earnings per share (EPS) of ($0.35). Learn more on analysts' earnings estimate vs. INZY's actual earnings.

How much profit does Inozyme Pharma generate each year?

Inozyme Pharma (NASDAQ:INZY) has a recorded net income of -$71.17 million. INZY has generated -$1.37 earnings per share over the last four quarters.

What is Inozyme Pharma's EPS forecast for next year?

Inozyme Pharma's earnings are expected to decrease from ($1.59) per share to ($1.61) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:INZY) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners